Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fulcrum Therapeutics (FULC) Assets Average (2019 - 2026)

Fulcrum Therapeutics (FULC) has 8 years of Assets Average data on record, last reported at $356.5 million in Q1 2026.

  • On a quarterly basis, Assets Average rose 41.66% to $356.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $356.5 million, a 41.66% increase, with the full-year FY2025 number at $313.5 million, up 20.95% from a year prior.
  • Assets Average reached $356.5 million in Q1 2026 per FULC's latest filing, up from $290.6 million in the prior quarter.
  • Over the last five years, Assets Average for FULC hit a ceiling of $356.5 million in Q1 2026 and a floor of $207.7 million in Q2 2022.
  • A 5-year average of $262.2 million and a median of $263.4 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: skyrocketed 59.15% in 2022, then fell 22.6% in 2025.
  • Tracing FULC's Assets Average over 5 years: stood at $237.2 million in 2022, then rose by 13.08% to $268.3 million in 2023, then rose by 0.59% to $269.9 million in 2024, then rose by 7.67% to $290.6 million in 2025, then grew by 22.7% to $356.5 million in 2026.
  • Business Quant data shows Assets Average for FULC at $356.5 million in Q1 2026, $290.6 million in Q4 2025, and $221.8 million in Q3 2025.